An update from ImExHS Limited ( (AU:IME) ) is now available.
IMEXHS Limited has successfully raised $2.5 million to support its growth initiatives, including the expansion of its AI-enabled software platform, Aquila+. The company is also in advanced negotiations for a significant radiology contract with a public hospital district in Bogota, Colombia. The capital raised will be used to provide working capital and drive sales growth, with strong support from institutional and sophisticated investors, as well as company directors. This financial boost positions IMEXHS to enhance its market presence and improve profitability in 2025.
More about ImExHS Limited
IMEXHS Limited operates in the medical imaging industry, focusing on providing advanced radiology services and AI-enabled software solutions. The company’s primary product, Aquila+, is a software platform designed to enhance radiology operations, and it is actively pursuing growth in this sector.
YTD Price Performance: 3.95%
Average Trading Volume: 33,851
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$18.36M
Find detailed analytics on IME stock on TipRanks’ Stock Analysis page.